Levity Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: semaglutide from $1199/month
Levity falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked July 2026
Expect between 1,199 and 1,599 dollars a month once the first-month discount falls away, the exact figure depending on which drug. That single monthly fee absorbs the prescription, the consultation, delivery, follow-up care and clinical support without limit. No compounded GLP-1 is dispensed. Levity carries only FDA-approved branded products, Mounjaro (tirzepatide), Wegovy (semaglutide) and Ozempic (semaglutide), each a weekly injectable pen. A LegitScript badge is displayed and both pharmacy and physician leaders are named. It operates in 34 states, with progress tracking.
Is Levity legit?
Levity is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate Levity 7.2/10 overall.
Is there a Levity promo or coupon code?
Levity publishes the code WELCOME ($50 off first month with code WELCOME (e.g. first month from $129, then from $179/mo)). You enter it at checkout on Levity's own site. Other codes for Levity circulate on coupon sites, and we cannot vouch for those.
See how Levity compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Levity
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Levity at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Branded Mounjaro, Branded Wegovy, Branded Ozempic
- Starting price
- $1,199/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 36 states
- FDA status
- 1 FDA warning letter (details below)
How Levity scores
Six columns, each one computed from something Levity has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.7/10$1299/month is 4% above the $1249 median for brand-name tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.5/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
7.8/10Serves 36 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Levity
Last checked July 2026- Checked the listed price across 3 dose or plan tiers
- Checked state coverage: 36 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Levity
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Levity involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Levity shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Levity which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: tirzepatide $1299, semaglutide $1199. That leaves out membership fees, first-month rates and insurance copays.
- Levity serves 36 of 50 states, so check that yours is one of them.
- The FDA has issued Levity a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
Contacting Levity
- Phone
- (855) 644-0928
- Hours
- Mon-Fri, 9am-5pm EST
Cancelling Levity
Taken from the terms Levity publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Not published by the seller
- Early-termination fee
- None
GLP-1 medications Levity offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off Levity's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $1299 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
Against it
- Semaglutide costs $1199 a month, 20% above the $997 median for brand-name semaglutide across the sellers we compare
- Serves only 36 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Levity a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
What Levity charges
Levity lists $1,199/month.
- Brand-name tirzepatide: $1,299/month
- Brand-name semaglutide: $1,599/month
- Brand-name semaglutide: $1,199/month
For brand-name tirzepatide, the median across the sellers we compare is $1,249/month, so Levity's $1,299 lands mid-market. Price is unlikely to be the deciding factor.
MangoRx dispenses semaglutide and tirzepatide from $299/month, which makes it the fair comparison to run before you commit here.
What Levity dispenses
Levity prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed.
Safety and disclosure
Levity tells you its price before you start the medical questionnaire and the 36 states it serves. The FDA has issued Levity a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Levity bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
Our read
Levity lands mid-market on price. The catch is disclosure, which is why Levity scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
Levity falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Before you pay Levity
Starting at $1,199 a month. Check today's price, then start the intake.
Where Levity is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
- If your state is outside the area this one covers, consider Trimi Health.
Compare Levity head to head
The sellers closest to Levity on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Levity has an FDA warning letter on record, dated February 20, 2026
This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this Levity review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Levity's current pricing
Plans start at $1,199 a month. Whether you qualify is a clinician's decision, made after your intake.